DR. ANNA PARK MD
Prescription History 1295730521
Ophthalmology in Silver Spring, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ANNA PARK MD, an active Ophthalmology specialist practicing in Silver Spring, MD. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 254 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 102 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| Latanoprost | 102 | $33.43 | ≈ Typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 102 Medicare prescriptions for Latanoprost, about 86% of the volume of the typical Maryland prescriber of this medication (119). Medicare paid an average of $33.43 per fill, versus $21.84 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 243.3 30-Day Fills standardized to 30-day supplies 7,271 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 33 | $31.39▼ below MD avg | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 33 Medicare prescriptions for Prednisolone Acetate, about a third of the volume of the typical Maryland prescriber of this medication (88). Medicare paid an average of $31.39 per fill, versus $54.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 36.4 30-Day Fills standardized to 30-day supplies 748 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 26 | $26.33▼ below MD avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 26 Medicare prescriptions for Brimonidine Tartrate, about half the volume of the typical Maryland prescriber of this medication (55). Medicare paid an average of $26.33 per fill, versus $49.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 58.3 30-Day Fills standardized to 30-day supplies 1,750 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 26 | $68.53▼ below MD avg | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 26 Medicare prescriptions for Timolol Maleate, about the same volume as the typical Maryland prescriber of this medication (23). Medicare paid an average of $68.53 per fill, versus $500.63 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 64 30-Day Fills standardized to 30-day supplies 1,920 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 23 | $44.22 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 23 Medicare prescriptions for Dorzolamide-Timolol, about a third of the volume of the typical Maryland prescriber of this medication (81). Medicare paid an average of $44.22 per fill, versus $35.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48.1 30-Day Fills standardized to 30-day supplies 1,444 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 16 | $44.94 | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 16 Medicare prescriptions for Dorzolamide Hcl, about a third of the volume of the typical Maryland prescriber of this medication (43). Medicare paid an average of $44.94 per fill, versus $31.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.7 30-Day Fills standardized to 30-day supplies 715 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 15 | $13.20▼ below MD avg | ▼ Less than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 15 Medicare prescriptions for Erythromycin, about half the volume of the typical Maryland prescriber of this medication (35). Medicare paid an average of $13.20 per fill, versus $18.58 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 17 30-Day Fills standardized to 30-day supplies 210 Days of Medication total across all patients in 2023 | |||
| MoxifloxacinMoxifloxacin Hcl | 13 | $34.26 | ▼ Less than typical |
About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾ A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. In 2023, this provider wrote 13 Medicare prescriptions for Moxifloxacin, about a quarter of the volume of the typical Maryland prescriber of this medication (65). Medicare paid an average of $34.26 per fill, versus $30.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 171 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. ANNA PARK MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Silver Spring, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MD prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
